Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
US Stock MarketDetailed Quotes
WGRX Wellgistics Health
- 4.070
- -0.100-2.40%
Trading Apr 24 10:38 ET
211.41MMarket Cap-30.83P/E (TTM)
4.140High4.010Low15.96KVolume4.080Open4.170Pre Close64.75KTurnover1.77%Turnover RatioLossP/E (Static)51.94MShares5.69052wk High31.31P/B3.66MFloat Cap2.32052wk Low--Dividend TTM900.00KShs Float5.690Historical High--Div YieldTTM3.12%Amplitude2.320Historical Low4.058Avg Price1Lot Size
Wellgistics Health Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||
| Cash flow from continuing operating activities | -250.86%-1.22M | -475.61%-2.66M | 1,073.75%1.33M | -349.14K | -462.06K | 112.94K | 0 | 0 |
| Net income from continuing operations | -136.77%-6.86M | -302.52%-4.33M | -106.69%-1.87M | -55,055.89%-2.9M | -20,398.13%-1.08M | ---903.31K | ---5.25K | ---5.25K |
| Depreciation and amortization | --1.11M | --647.24K | --454.63K | --0 | --0 | ---- | ---- | ---- |
| Change In working capital | 31.24%3.34M | -120.02%-122.94K | 166.80%2.71M | 48,405.68%2.55M | 11,597.07%614.1K | --1.02M | --5.25K | --5.25K |
| -Change in receivables | ---40.08K | ---2.98K | ---37.04K | --0 | --0 | --0 | ---- | ---- |
| -Change in inventory | ---72.36K | --294.7K | ---383.16K | --0 | --0 | --0 | ---- | ---- |
| -Change in prepaid assets | --11.44K | ---524 | ---- | --0 | --0 | ---- | ---- | ---- |
| -Change in payables and accrued expense | -75.77%682.26K | -150.07%-498.89K | 22.68%1.11M | 53,533.43%2.82M | 18,877.20%996.3K | --903.25K | --5.25K | --5.25K |
| -Change in other current assets | ---587.54K | ---590.54K | ---- | --0 | --0 | ---- | ---- | ---- |
| -Change in other current liabilities | --22.09K | --1.68K | ---1.71K | --0 | --0 | --0 | ---- | ---- |
| -Change in other working capital | 1,335.58%3.33M | 276.24%673.62K | --2.01M | ---269.21K | ---382.21K | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||
| Operating cash flow | -250.86%-1.22M | -475.61%-2.66M | 1,073.75%1.33M | ---349.14K | ---462.06K | --112.94K | --0 | --0 |
| Investing cash flow | ||||||||
| Cash flow from continuing investing activities | 469.07K | 838.41K | -315.94K | 0 | 0 | 0 | ||
| Net intangibles purchase and sale | ---377.29K | ---112.44K | ---217.05K | --0 | --0 | --0 | ---- | ---- |
| Net business purchase and sale | --931.37K | --1M | ---98.89K | --0 | --0 | --0 | ---- | ---- |
| Net other investing changes | ---85.01K | ---49.15K | --0 | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||
| Investing cash flow | --469.07K | --838.41K | ---315.94K | --0 | --0 | --0 | ---- | ---- |
| Financing cash flow | ||||||||
| Cash flow from continuing financing activities | 408.67%1.78M | 487.55%2.06M | -283.52K | 350.5K | 350K | 0 | 0 | 0 |
| Net issuance payments of debt | 77.34%620.7K | 158.35%904.22K | ---- | --350K | --350K | ---- | --0 | --0 |
| Net common stock issuance | 1,900.00%10K | --0 | --0 | --500 | --0 | --0 | --0 | --0 |
| Net other financing activities | --1.15M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||
| Financing cash flow | 408.67%1.78M | 487.55%2.06M | ---283.52K | --350.5K | --350K | --0 | --0 | --0 |
| Net cash flow | ||||||||
| Beginning cash position | --1.36K | 599.30%793.15K | 13,853.13%66.98K | --0 | --113.42K | --480 | --0 | --0 |
| Current changes in cash | 75,191.20%1.03M | 309.88%235.19K | 542.97%726.17K | --1.36K | ---112.06K | --112.94K | ---- | ---- |
| End cash Position | 75,291.20%1.03M | 75,291.20%1.03M | 599.30%793.15K | --1.36K | --1.36K | --113.42K | --0 | --0 |
| Free cash flow | -358.93%-1.6M | -499.94%-2.77M | 881.56%1.11M | ---349.14K | ---462.06K | --112.94K | --0 | --0 |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- |
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
